| Abdominal lymphadenopathy | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Agranulocytosis | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00020 events20 affected9,562 at risk
- EG00114 events14 affected9,531 at risk
|
| Anaemia macrocytic | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anaemia of chronic disease | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Anaemia of malignant disease | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Anaemia vitamin b12 deficiency | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Deficiency anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Disseminated intravascular coagulation | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events10 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Hypochromic anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Immune thrombocytopenic purpura | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Increased tendency to bruise | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00026 events26 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Leukocytosis | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Lymphadenopathy | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Nephrogenic anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Normochromic normocytic anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Normocytic anaemia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pancytopenia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Splenic infarction | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Spontaneous haematoma | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Spontaneous haemorrhage | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00020 events20 affected9,562 at risk
- EG00122 events22 affected9,531 at risk
|
| Acute left ventricular failure | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events5 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG000133 events126 affected9,562 at risk
- EG001203 events197 affected9,531 at risk
|
| Adams-stokes syndrome | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG000239 events200 affected9,562 at risk
- EG001267 events251 affected9,531 at risk
|
| Angina unstable | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG000403 events354 affected9,562 at risk
- EG001449 events405 affected9,531 at risk
|
| Aortic valve disease | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Aortic valve incompetence | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Aortic valve stenosis | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG00114 events14 affected9,531 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0015 events3 affected9,531 at risk
|
| Arteriosclerosis coronary artery | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00084 events82 affected9,562 at risk
- EG00180 events76 affected9,531 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00013 events12 affected9,562 at risk
- EG00114 events13 affected9,531 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Atrial thrombosis | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Atrioventricular block | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00016 events16 affected9,562 at risk
- EG00118 events18 affected9,531 at risk
|
| Atrioventricular block first degree | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Atrioventricular block second degree | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00012 events12 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Bifascicular block | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bradyarrhythmia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Bradycardia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00015 events15 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Bundle branch block left | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bundle branch block right | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG00112 events12 affected9,531 at risk
|
| Cardiac disorder | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00084 events64 affected9,562 at risk
- EG001108 events87 affected9,531 at risk
|
| Cardiac failure acute | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00027 events20 affected9,562 at risk
- EG00115 events14 affected9,531 at risk
|
| Cardiac failure chronic | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00019 events18 affected9,562 at risk
- EG00144 events30 affected9,531 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00071 events60 affected9,562 at risk
- EG00153 events47 affected9,531 at risk
|
| Cardiac tamponade | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cardiac valve disease | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cardiac ventricular scarring | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Cardiogenic shock | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Cardiomyopathy | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cardiopulmonary failure | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cardiovascular insufficiency | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00089 events85 affected9,562 at risk
- EG00195 events90 affected9,531 at risk
|
| Coronary artery insufficiency | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Coronary artery occlusion | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Coronary artery stenosis | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00014 events14 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Dressler's syndrome | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Extrasystoles | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hypertensive heart disease | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ischaemic cardiomyopathy | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events2 affected9,531 at risk
|
| Left ventricular dysfunction | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Left ventricular failure | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events7 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Microvascular coronary artery disease | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Mitral valve stenosis | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Myocardial fibrosis | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00043 events41 affected9,562 at risk
- EG00166 events65 affected9,531 at risk
|
| Myocardial ischaemia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00037 events36 affected9,562 at risk
- EG00150 events47 affected9,531 at risk
|
| Myocarditis | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Nodal arrhythmia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Palpitations | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pericardial haemorrhage | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pericarditis | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pericarditis constrictive | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Prinzmetal angina | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0014 events3 affected9,531 at risk
|
| Pulmonary valve incompetence | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Right ventricular failure | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Sinoatrial block | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Sinus arrhythmia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Sinus bradycardia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Sinus node dysfunction | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Sinus tachycardia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Stress cardiomyopathy | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Supraventricular extrasystoles | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG00111 events9 affected9,531 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Tricuspid valve incompetence | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Ventricular arrhythmia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Ventricular asystole | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Ventricular extrasystoles | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events10 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Corneal dystrophy | Congenital, familial and genetic disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Glucose-6-phosphate dehydrogenase deficiency | Congenital, familial and genetic disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Neurofibromatosis | Congenital, familial and genetic disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Deafness | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Deafness neurosensory | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Deafness unilateral | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Ear pain | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Eustachian tube dysfunction | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hypoacusis | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Inner ear disorder | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Meniere's disease | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Sudden hearing loss | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Tinnitus | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tympanic membrane perforation | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tympanosclerosis | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG00013 events13 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Vertigo positional | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Vestibular disorder | Ear and labyrinth disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Adrenal insufficiency | Endocrine disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Goitre | Endocrine disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events5 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hyperparathyroidism | Endocrine disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hyperparathyroidism primary | Endocrine disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hyperthyroidism | Endocrine disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hypothyroidism | Endocrine disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thyroiditis subacute | Endocrine disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Age-related macular degeneration | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Aphakia | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cataract | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG00026 events22 affected9,562 at risk
- EG00135 events30 affected9,531 at risk
|
| Cataract cortical | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cataract diabetic | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cataract nuclear | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Corneal degeneration | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diabetic retinopathy | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Entropion | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Eye haemorrhage | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Eyelid ptosis | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Glaucoma | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0014 events3 affected9,531 at risk
|
| Lacrimal disorder | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Macular degeneration | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Macular fibrosis | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Macular oedema | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Macular pseudohole | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Maculopathy | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Open angle glaucoma | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Optic ischaemic neuropathy | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Retinal artery occlusion | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Retinal artery thrombosis | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Retinal degeneration | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Retinal detachment | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Retinal haemorrhage | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Retinal vein occlusion | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Retinal vein thrombosis | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Retinopathy | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Retinopathy proliferative | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Rhegmatogenous retinal detachment | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Strabismus | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Trichiasis | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ulcerative keratitis | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Visual impairment | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vitreous haemorrhage | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Vitreous opacities | Eye disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Abdominal distension | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Abdominal pain lower | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Abdominal wall haematoma | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anal fissure | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Anal fistula | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anal inflammation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Appendicitis noninfective | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Appendix disorder | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ascites | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Barrett's oesophagus | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bezoar | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Change of bowel habit | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Chronic gastritis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Chronic gastrointestinal bleeding | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Coeliac disease | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Dental caries | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Diabetic gastroparesis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Diaphragmatic hernia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00018 events18 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Diverticular perforation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diverticulitis oesophageal | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Diverticulum intestinal | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Diverticulum intestinal haemorrhagic | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events5 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Duodenal polyp | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Duodenal ulcer | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events7 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Duodenitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Enteritis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Enterocolitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Epigastric discomfort | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Erosive oesophagitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Faecaloma | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Faeces discoloured | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Food poisoning | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Functional gastrointestinal disorder | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastric antral vascular ectasia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gastric disorder | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gastric haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gastric polyps | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0018 events6 affected9,531 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00018 events18 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Gastric ulcer perforation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG00112 events12 affected9,531 at risk
|
| Gastritis erosive | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Gastritis haemorrhagic | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastroduodenal ulcer | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gastrointestinal angiodysplasia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal disorder | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00044 events43 affected9,562 at risk
- EG00123 events22 affected9,531 at risk
|
| Gastrointestinal inflammation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal ischaemia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gastrointestinal motility disorder | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gastrointestinal polyp haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal stenosis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events5 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Haematochezia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Haemorrhagic erosive gastritis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hernial eventration | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events4 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Ileus paralytic | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Incarcerated inguinal hernia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00016 events16 affected9,562 at risk
- EG00120 events20 affected9,531 at risk
|
| Intestinal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Intestinal ischaemia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events4 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Intestinal perforation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Intestinal polyp | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Intestinal pseudo-obstruction | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Intestinal strangulation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Large intestinal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Large intestine perforation | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Large intestine polyp | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00018 events18 affected9,562 at risk
- EG00114 events14 affected9,531 at risk
|
| Lower gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Lumbar hernia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Mallory-weiss syndrome | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Mechanical ileus | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Melaena | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00012 events12 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Obstruction gastric | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Obstructive pancreatitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Oesophageal motility disorder | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Oesophageal spasm | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Oesophageal ulcer | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Oesophageal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Oesophagitis ulcerative | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pancreatic mass | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pancreatic pseudocyst | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00014 events11 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0016 events5 affected9,531 at risk
|
| Pancreatitis chronic | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pancreatolithiasis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Peptic ulcer | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Peptic ulcer haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Periodontal disease | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Peritoneal adhesions | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Peritoneal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Proctitis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00013 events13 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Rectal polyp | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Rectal prolapse | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Reflux gastritis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Salivary gland calculus | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Small intestinal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Subileus | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Swollen tongue | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Tooth disorder | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Tooth socket haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Ulcerative gastritis | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Umbilical hernia | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Umbilical hernia, obstructive | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00023 events22 affected9,562 at risk
- EG00110 events10 affected9,531 at risk
|
| Varices oesophageal | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Administration site phlebitis | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Asthenia | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Capsular contracture associated with breast implant | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cardiac death | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Catheter site haemorrhage | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Chest discomfort | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Chest pain | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG00111 events11 affected9,531 at risk
|
| Complication associated with device | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Death | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG00052 events52 affected9,562 at risk
- EG00160 events60 affected9,531 at risk
|
| Drowning | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Facial pain | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fatigue | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Foreign body reaction | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gait disturbance | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gait inability | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| General physical health deterioration | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Impaired healing | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Medical device site haemorrhage | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Mucosal exfoliation | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Multiple organ dysfunction syndrome | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Necrobiosis | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Necrosis | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Nodule | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG00060 events54 affected9,562 at risk
- EG00172 events66 affected9,531 at risk
|
| Oedema | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Oedema peripheral | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Pacemaker generated arrhythmia | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pain | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Peripheral swelling | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pyrexia | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Sudden cardiac death | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Sudden death | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Ulcer haemorrhage | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Vascular stent occlusion | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vascular stent stenosis | General disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0015 events4 affected9,531 at risk
|
| Acute hepatic failure | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bile duct obstruction | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Biliary colic | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Biliary dyskinesia | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0015 events4 affected9,531 at risk
|
| Cholangitis acute | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Cholangitis chronic | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00014 events13 affected9,562 at risk
- EG00127 events23 affected9,531 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00019 events19 affected9,562 at risk
- EG00115 events14 affected9,531 at risk
|
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00024 events23 affected9,562 at risk
- EG00125 events25 affected9,531 at risk
|
| Cholestasis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Chronic hepatitis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cirrhosis alcoholic | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Drug-induced liver injury | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gallbladder disorder | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Hepatic failure | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hepatic function abnormal | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hepatitis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hepatitis acute | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Jaundice | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Jaundice cholestatic | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Liver injury | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Non-alcoholic steatohepatitis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Portal vein thrombosis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Steatohepatitis | Hepatobiliary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Allergy to arthropod bite | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anaphylactic reaction | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Anaphylactic shock | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Contrast media allergy | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Haemophagocytic lymphohistiocytosis | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Sarcoidosis | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Transplant rejection | Immune system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Abdominal abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Abdominal sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Abdominal wall abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Abscess jaw | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Abscess limb | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Abscess neck | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Acinetobacter infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Acute endocarditis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Acute hepatitis b | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Acute sinusitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Anal abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Anal fistula infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Appendiceal abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Appendicitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00014 events13 affected9,562 at risk
- EG00110 events10 affected9,531 at risk
|
| Appendicitis perforated | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Arthritis infective | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Atypical pneumonia | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bacteraemia | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bacterial diarrhoea | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bacterial sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Biliary sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Brain abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Breast abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Breast cellulitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bronchiolitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bronchitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00018 events18 affected9,562 at risk
- EG00123 events22 affected9,531 at risk
|
| Bronchitis bacterial | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bursitis infective | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Campylobacter gastroenteritis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cellulitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00040 events35 affected9,562 at risk
- EG00151 events45 affected9,531 at risk
|
| Cellulitis gangrenous | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cellulitis of male external genital organ | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cholangitis infective | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cholecystitis infective | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Chronic hepatitis c | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Chronic sinusitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Clostridium difficile infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0015 events3 affected9,531 at risk
|
| Complicated appendicitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cystitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Dacryocystitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Dengue fever | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Dengue haemorrhagic fever | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Device related infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Device related sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diabetic foot infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0004 events3 affected9,562 at risk
- EG0014 events3 affected9,531 at risk
|
| Diabetic gangrene | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Diarrhoea infectious | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diverticulitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00012 events11 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Diverticulitis intestinal haemorrhagic | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Dysentery | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ear infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Emphysematous cystitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Endocarditis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Endophthalmitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Enteritis infectious | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Enterobacter pneumonia | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Enterocolitis infectious | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Epididymitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Epiglottitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events2 affected9,531 at risk
|
| Erysipelas | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00012 events12 affected9,562 at risk
- EG00113 events10 affected9,531 at risk
|
| Escherichia urinary tract infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Eye infection viral | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Febrile infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Fungal infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gangrene | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG00113 events12 affected9,531 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00015 events14 affected9,562 at risk
- EG00119 events18 affected9,531 at risk
|
| Gastroenteritis bacterial | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastroenteritis salmonella | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Gastroenteritis viral | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Gastrointestinal infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Genitourinary tract infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Graft infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Groin abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| H1n1 influenza | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Helicobacter gastritis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Helicobacter infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hepatitis a | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hepatitis c | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hepatitis e | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Herpes ophthalmic | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Herpes virus infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Herpes zoster | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Incision site abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Infected bite | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Infected cyst | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Infected dermal cyst | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Infected skin ulcer | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Infectious colitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Infectious pleural effusion | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Infective exacerbation of bronchiectasis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events2 affected9,531 at risk
|
| Infective exacerbation of chronic obstructive airways disease | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Influenza | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG00110 events10 affected9,531 at risk
|
| Joint abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Kidney infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Labyrinthitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Liver abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Localised infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0008 events7 affected9,562 at risk
- EG0018 events7 affected9,531 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Ludwig angina | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lung abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Lung infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00012 events10 affected9,562 at risk
- EG0017 events6 affected9,531 at risk
|
| Meningitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Meningitis bacterial | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Meningococcal infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Necrotising fasciitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Neutropenic sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Oesophageal candidiasis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ophthalmic herpes zoster | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Orchitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Osteomyelitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00016 events14 affected9,562 at risk
- EG0018 events7 affected9,531 at risk
|
| Osteomyelitis acute | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Osteomyelitis chronic | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Otitis media | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Otitis media acute | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Otitis media chronic | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pancreas infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Papilloma viral infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Parainfluenzae virus infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Parotitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Perineal abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Periodontitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Periorbital cellulitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Peritonitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Peritonitis bacterial | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Peritonsillar abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pharyngeal abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pneumocystis jirovecii infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pneumonia | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG000137 events130 affected9,562 at risk
- EG001153 events147 affected9,531 at risk
|
| Pneumonia bacterial | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Pneumonia escherichia | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pneumonia influenzal | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pneumonia mycoplasmal | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pneumonia staphylococcal | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pneumonia streptococcal | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pneumonia viral | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Post procedural infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Post procedural sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Postoperative abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Prostatic abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Prostatitis escherichia coli | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG00112 events12 affected9,531 at risk
|
| Pyelonephritis chronic | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Rectal abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Respiratory tract infection viral | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Salmonellosis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Scrotal abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00015 events14 affected9,562 at risk
- EG00120 events20 affected9,531 at risk
|
| Septic shock | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Sinusitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Skin infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Soft tissue infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Streptococcal infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Streptococcal sepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Subcutaneous abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Tonsillitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Tooth abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Tracheobronchitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Tracheobronchitis mycoplasmal | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tuberculosis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tuberculosis of genitourinary system | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Ureteritis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00037 events33 affected9,562 at risk
- EG00150 events36 affected9,531 at risk
|
| Urinary tract infection bacterial | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Urosepsis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG00013 events12 affected9,562 at risk
- EG00111 events10 affected9,531 at risk
|
| Vestibular neuronitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Viral infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Vulval abscess | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Vulval cellulitis | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| West nile viral infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Wound infection | Infections and infestations | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0015 events4 affected9,531 at risk
|
| Abdominal injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Accident at home | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Acetabulum fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Adrenal gland injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anastomotic leak | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Anastomotic stenosis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Arterial bypass thrombosis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Arthropod bite | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Avulsion fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Brain contusion | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Burns third degree | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Carbon monoxide poisoning | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Carotid artery restenosis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cataract traumatic | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cervical vertebral fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Clavicle fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Concussion | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Coronary artery restenosis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Coronary vascular graft occlusion | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Coronary vascular graft stenosis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Craniocerebral injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Dislocation of sternum | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Epidural haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Extradural haematoma | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Extraskeletal ossification | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Failure to anastomose | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG00115 events15 affected9,531 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Foreign body | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Foreign body in gastrointestinal tract | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fractured sacrum | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Heat stroke | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG00012 events12 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Hyphaema | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Incisional hernia | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Intervertebral disc injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Ligament injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ligament rupture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Ligament sprain | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG00013 events12 affected9,562 at risk
- EG0018 events7 affected9,531 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Lumbosacral plexus injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Median nerve injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Meniscus injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Multiple fractures | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Multiple injuries | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Muscle injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Muscle strain | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Nail injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Nerve injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Nerve root injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Nerve root injury lumbar | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Patella fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Periorbital haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Periprocedural myocardial infarction | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Post procedural complication | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Post procedural fever | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Post procedural haematoma | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG00011 events11 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Postoperative ileus | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Postoperative respiratory failure | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Postoperative thoracic procedure complication | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Procedural complication | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Procedural pain | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pubis fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pulmonary contusion | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Radiation pneumonitis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0007 events6 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG00110 events10 affected9,531 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Scapula fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Seroma | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Shunt malfunction | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Skeletal injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Skin abrasion | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Skin injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Skin laceration | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Skull fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Skull fractured base | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Spinal column injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Spinal cord injury cervical | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Stomal hernia | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Subcutaneous haematoma | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG00023 events23 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Subdural haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Tendon injury | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Thoracic vertebral fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Tibia fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Toxicity to various agents | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Traumatic fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Traumatic haematoma | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Traumatic haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Traumatic haemothorax | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Traumatic intracranial haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG00011 events11 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Ulna fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Urinary retention postoperative | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Vascular graft complication | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vascular graft thrombosis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Wound | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Wound haemorrhage | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Wound necrosis | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Alanine aminotransferase increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bile output decreased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Blood follicle stimulating hormone increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Blood glucose fluctuation | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Blood glucose increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Blood lactic acid increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Blood potassium increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events2 affected9,531 at risk
|
| Blood pressure increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Blood urine present | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cardiac stress test abnormal | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Electrocardiogram qrs complex prolonged | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Electrocardiogram st segment depression | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Electrocardiogram abnormal | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Glycosylated haemoglobin increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Haemoglobin decreased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Heart rate irregular | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hepatic enzyme increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hepatitis b surface antigen positive | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Occult blood positive | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Oxygen saturation decreased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Prostatic specific antigen increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Troponin increased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Weight decreased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| White blood cell count decreased | Investigations | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Decreased appetite | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events6 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG00028 events24 affected9,562 at risk
- EG00146 events42 affected9,531 at risk
|
| Diabetes mellitus inadequate control | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG00055 events50 affected9,562 at risk
- EG00178 events60 affected9,531 at risk
|
| Diabetic complication | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG00011 events10 affected9,562 at risk
- EG00113 events11 affected9,531 at risk
|
| Diabetic metabolic decompensation | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG00117 events17 affected9,531 at risk
|
| Euglycaemic diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fluid overload | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events5 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG00021 events20 affected9,562 at risk
- EG00124 events22 affected9,531 at risk
|
| Hyperglycaemic hyperosmolar nonketotic syndrome | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Hypertriglyceridaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG00039 events33 affected9,562 at risk
- EG00126 events25 affected9,531 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hypophosphataemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hypovolaemia | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Ketoacidosis | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Lactic acidosis | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Obesity | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Type 2 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG00012 events12 affected9,562 at risk
- EG00119 events19 affected9,531 at risk
|
| Vitamin d deficiency | Metabolism and nutrition disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Arthritis reactive | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG00011 events10 affected9,562 at risk
- EG00115 events14 affected9,531 at risk
|
| Bone pain | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Chest wall mass | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Chondromalacia | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Compartment syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Costochondritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Crystal arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diabetic amyotrophy | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Dupuytren's contracture | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Facial asymmetry | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fistula | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Flank pain | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gouty arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Gouty tophus | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Inguinal mass | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Intervertebral disc disorder | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG00017 events16 affected9,562 at risk
- EG00120 events19 affected9,531 at risk
|
| Intervertebral disc space narrowing | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Joint contracture | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Joint swelling | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Loose body in joint | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lumbar spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG00013 events13 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Meniscal degeneration | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Muscle disorder | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG00115 events15 affected9,531 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Myofascitis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Myopathy | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Myositis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Neuropathic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG00051 events47 affected9,562 at risk
- EG00157 events55 affected9,531 at risk
|
| Osteochondrosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Osteonecrosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Osteopenia | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Osteoporotic fracture | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Osteorrhagia | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Patellofemoral pain syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Pathological fracture | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Periarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events2 affected9,531 at risk
|
| Polymyalgia rheumatica | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pseudarthrosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Psoriatic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Rhabdomyolysis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Rheumatoid arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Sacroiliitis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Scoliosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Seronegative arthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Sjogren's syndrome | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Soft tissue disorder | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Spinal ligament ossification | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG00112 events11 affected9,531 at risk
|
| Spinal pain | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Spondylitis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Spondylolisthesis | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Synovial cyst | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tendon disorder | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tenosynovitis stenosans | Musculoskeletal and connective tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Abdominal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Acute myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Acute promyelocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Adenocarcinoma gastric | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG00014 events14 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Adenocarcinoma pancreas | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Adrenal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Adrenal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Anal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| B-cell lymphoma stage i | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0006 events5 affected9,562 at risk
- EG00110 events9 affected9,531 at risk
|
| Benign gastric neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Benign neoplasm of bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Benign ovarian tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bile duct cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Bladder cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Bladder transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Bladder transitional cell carcinoma stage ii | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bone cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Brain neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Brain neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Breast cancer female | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Carcinoid tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cerebellopontine angle tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cervix carcinoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cervix carcinoma stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cholangiocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0004 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cholesteatoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Chordoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Chronic lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Chronic myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Clear cell renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG00012 events12 affected9,562 at risk
- EG00116 events16 affected9,531 at risk
|
| Colon cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Colon neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Colorectal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Colorectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Cutaneous lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Endometrial adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Endometrial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Endometrial cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Endometrial cancer stage i | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Endometrial cancer stage ii | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fibroadenoma of breast | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fibrosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Fibrous histiocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gallbladder adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gallbladder adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gallbladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gallbladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Gastric adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG00110 events10 affected9,531 at risk
|
| Gastric neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Gastrointestinal lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal stromal tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Gastrointestinal tract adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Glioblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hepatic cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Hepatic cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hepatobiliary neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hepatocellular carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG00010 events9 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Invasive breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Invasive ductal breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Large intestine benign neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Laryngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Laryngeal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lentigo maligna | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lip and/or oral cavity cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events2 affected9,531 at risk
|
| Lip neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Lipofibroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG00014 events14 affected9,562 at risk
- EG00120 events20 affected9,531 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Malignant neoplasm of renal pelvis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Malignant neoplasm of unknown primary site | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Malignant neoplasm papilla of vater | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Meningioma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Metastases to central nervous system | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Metastases to liver | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Metastases to lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Metastases to peritoneum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Metastases to pleura | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Metastatic gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Metastatic malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Monoclonal gammopathy | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Muscle neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Musculoskeletal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Myelodysplastic syndrome | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Nasopharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Neoplasm prostate | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Non-hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Non-small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Oesophageal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Oesophageal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Oral neoplasm benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Osteoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Ovarian cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Ovarian fibroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ovarian granulosa cell tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ovarian neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG00013 events12 affected9,562 at risk
- EG00112 events12 affected9,531 at risk
|
| Pancreatic carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pancreatic neuroendocrine tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pancreatic sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Papillary cystadenoma lymphomatosum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Papillary thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Parathyroid tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Penis carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Phyllodes tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pituitary tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pituitary tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Plasma cell myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Plasmacytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pleomorphic liposarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pleural neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG00031 events31 affected9,562 at risk
- EG00136 events36 affected9,531 at risk
|
| Prostate cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Prostate cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Prostate cancer stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Prostate cancer stage iii | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Prostatic adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Rectal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Rectal cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Rectal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Rectosigmoid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Rectosigmoid cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Renal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Retroperitoneal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Salivary gland adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Small cell lung cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Small intestine adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Small intestine carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Soft tissue sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Squamous cell carcinoma of lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Squamous cell carcinoma of the cervix | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Squamous cell carcinoma of the oral cavity | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Squamous cell carcinoma of the tongue | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thyroid adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Thyroid cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Thyroid neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tongue neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Tonsil cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Transitional cell cancer of the renal pelvis and ureter | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0005 events4 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Tumour haemorrhage | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Uterine cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vulval cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Ageusia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Altered state of consciousness | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Amnesia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Ataxia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Balance disorder | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Basal ganglia haemorrhage | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Basal ganglia infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Brain hypoxia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Brain injury | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Brain stem haemorrhage | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Brain stem infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Brain stem stroke | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Carotid arteriosclerosis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Carotid artery disease | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Carotid artery occlusion | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00018 events18 affected9,562 at risk
- EG00122 events21 affected9,531 at risk
|
| Carotid sinus syndrome | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Cauda equina syndrome | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cerebellar haemorrhage | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cerebellar infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cerebellar stroke | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cerebral arteriosclerosis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cerebral atrophy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cerebral haematoma | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Cerebral infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00019 events18 affected9,562 at risk
- EG00128 events27 affected9,531 at risk
|
| Cerebral ischaemia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events7 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Cerebral small vessel ischaemic disease | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Cerebrovascular insufficiency | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cervical cord compression | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cervical radiculopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cervicobrachial syndrome | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Cluster headache | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cognitive disorder | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Coma | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Dementia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Dementia with lewy bodies | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diabetic coma | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diabetic neuropathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events9 affected9,562 at risk
- EG00114 events13 affected9,531 at risk
|
| Dizziness | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00015 events14 affected9,562 at risk
- EG00112 events12 affected9,531 at risk
|
| Dysarthria | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Embolic cerebral infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Embolic stroke | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Epilepsy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0017 events5 affected9,531 at risk
|
| Epileptic encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Essential tremor | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Facial paralysis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Focal dyscognitive seizures | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Generalised tonic-clonic seizure | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Haemorrhage intracranial | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Haemorrhagic stroke | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events10 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Haemorrhagic transformation stroke | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Headache | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hemianopia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hemiparesis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hepatic encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hydrocephalus | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hypertensive encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hypoaesthesia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hypoglycaemic coma | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Hypoglycaemic encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hypoglycaemic seizure | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hypoglycaemic unconsciousness | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Iiird nerve paralysis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Intracranial aneurysm | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Intracranial pressure increased | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ischaemic cerebral infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00088 events85 affected9,562 at risk
- EG001127 events119 affected9,531 at risk
|
| Lacunar infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events9 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Lacunar stroke | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Loss of consciousness | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Lumbosacral radiculopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Metabolic encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Microsleep | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Migraine | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Miller fisher syndrome | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Myasthenia gravis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Myelopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Nerve compression | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Normal pressure hydrocephalus | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Paralysis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Parkinson's disease | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0018 events7 affected9,531 at risk
|
| Parkinsonism | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Peripheral nerve lesion | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Petit mal epilepsy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Polyneuropathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Post-traumatic headache | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Presyncope | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Pseudoradicular syndrome | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Putamen haemorrhage | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Radicular pain | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Radiculopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Sciatica | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Sedation | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Seizure | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0017 events6 affected9,531 at risk
|
| Spinal cord compression | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Spinal epidural haematoma | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Subarachnoid haemorrhage | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Syncope | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00029 events26 affected9,562 at risk
- EG00128 events27 affected9,531 at risk
|
| Tension headache | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Thalamic infarction | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thalamus haemorrhage | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thoracic outlet syndrome | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Toxic encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Transient global amnesia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG00039 events39 affected9,562 at risk
- EG00134 events33 affected9,531 at risk
|
| Tremor | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vith nerve disorder | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vith nerve paralysis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vith nerve paresis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vascular dementia | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Vascular encephalopathy | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Vertebral artery dissection | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Vertebral artery stenosis | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Vertebrobasilar insufficiency | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vertigo cns origin | Nervous system disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Device dislocation | Product Issues | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Device failure | Product Issues | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Device loosening | Product Issues | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Device malfunction | Product Issues | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Device occlusion | Product Issues | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Adjustment disorder | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Affective disorder | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Anxiety | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Bipolar disorder | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Borderline personality disorder | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Confusional state | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Delirium | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Delirium tremens | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Depression | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events6 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Depression suicidal | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Disorientation | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Illness anxiety disorder | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Insomnia | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Major depression | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Mental disorder | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Neuropsychiatric symptoms | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Suicide attempt | Psychiatric disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Acute kidney injury | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00059 events56 affected9,562 at risk
- EG00143 events39 affected9,531 at risk
|
| Azotaemia | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bladder neck obstruction | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Bladder neck sclerosis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bladder outlet obstruction | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Bladder tamponade | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Calculus bladder | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Calculus urethral | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Calculus urinary | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events6 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Chronic kidney disease | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events9 affected9,562 at risk
- EG00115 events15 affected9,531 at risk
|
| Cystitis haemorrhagic | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Diabetic nephropathy | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Dysuria | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| End stage renal disease | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Glomerulonephritis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Glomerulosclerosis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00033 events32 affected9,562 at risk
- EG00113 events13 affected9,531 at risk
|
| Haemorrhage urinary tract | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hydronephrosis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Hypertensive nephropathy | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Micturition disorder | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Nephritic syndrome | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00019 events16 affected9,562 at risk
- EG00124 events21 affected9,531 at risk
|
| Nephropathy toxic | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Nephrotic syndrome | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Pelvi-ureteric obstruction | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Perinephritis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Proteinuria | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Renal artery arteriosclerosis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Renal artery occlusion | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Renal artery stenosis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Renal colic | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Renal disorder | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00017 events16 affected9,562 at risk
- EG00115 events15 affected9,531 at risk
|
| Renal haemorrhage | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Renal hypertension | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events10 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Renal injury | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Renal mass | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Stress urinary incontinence | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Tubulointerstitial nephritis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Ureteric stenosis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ureterolithiasis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG00020 events18 affected9,562 at risk
- EG00114 events13 affected9,531 at risk
|
| Urethral haemorrhage | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Urethral stenosis | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Urinary bladder polyp | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Urinary incontinence | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Urinary tract obstruction | Renal and urinary disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Acquired hydrocele | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Acquired phimosis | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG00026 events26 affected9,562 at risk
- EG00121 events21 affected9,531 at risk
|
| Breast mass | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cervical dysplasia | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Cervix disorder | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Cystocele | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Endometrial atrophy | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Endometrial hyperplasia | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Genital haemorrhage | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Gynaecomastia | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Postmenopausal haemorrhage | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Prostatic fibrosis | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Prostatic haemorrhage | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Prostatic obstruction | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Prostatism | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Prostatitis | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Prostatomegaly | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Uterine fibrosis | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Uterine haemorrhage | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Uterine polyp | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Uterine prolapse | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Vaginal haemorrhage | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vaginal prolapse | Reproductive system and breast disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events6 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00012 events11 affected9,562 at risk
- EG0017 events7 affected9,531 at risk
|
| Aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00018 events14 affected9,562 at risk
- EG0019 events7 affected9,531 at risk
|
| Asthmatic crisis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bronchial disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bronchial obstruction | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Bronchiectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Bronchospasm | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Choking | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00041 events27 affected9,562 at risk
- EG00157 events41 affected9,531 at risk
|
| Chronic respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events2 affected9,531 at risk
|
| Diaphragmatic paralysis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00036 events35 affected9,562 at risk
- EG00129 events29 affected9,531 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Emphysema | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Epiglottic cyst | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00020 events20 affected9,562 at risk
- EG00112 events11 affected9,531 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Hydrothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Idiopathic interstitial pneumonia | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Laryngeal oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lung disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Lung infiltration | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Mediastinal haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Nasal septum deviation | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Obstructive airways disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Organising pneumonia | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Orthopnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Paranasal cyst | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0016 events5 affected9,531 at risk
|
| Pleurisy | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pneumonitis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Pneumothorax spontaneous | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pulmonary arterial hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pulmonary congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00016 events16 affected9,562 at risk
- EG00119 events19 affected9,531 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Pulmonary mass | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events10 affected9,562 at risk
- EG0015 events5 affected9,531 at risk
|
| Pulmonary sarcoidosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Pulmonary toxicity | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Respiratory alkalosis | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Respiratory arrest | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Respiratory disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events8 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Restrictive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Sinus congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Actinic elastosis | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Angioedema | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Dermal cyst | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Dermatitis | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Diabetic foot | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG00032 events29 affected9,562 at risk
- EG00125 events18 affected9,531 at risk
|
| Diabetic ulcer | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ecchymosis | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Henoch-schonlein purpura | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Intertrigo | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Ischaemic skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events1 affected9,531 at risk
|
| Lichen planus | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Myxoid cyst | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Necrobiosis lipoidica diabeticorum | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Petechiae | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Prurigo | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Psoriasis | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Skin exfoliation | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Skin mass | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Skin necrosis | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG00112 events12 affected9,531 at risk
|
| Stevens-johnson syndrome | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Toxic skin eruption | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Accelerated hypertension | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Air embolism | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Angiopathy | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0008 events8 affected9,562 at risk
- EG0019 events9 affected9,531 at risk
|
| Aortic arteriosclerosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Aortic dissection | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Aortic stenosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0005 events5 affected9,562 at risk
- EG0018 events7 affected9,531 at risk
|
| Arterial occlusive disease | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Arterial stenosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Arterial thrombosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Artery dissection | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Atherosclerotic plaque rupture | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Blood pressure inadequately controlled | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events6 affected9,562 at risk
- EG0018 events8 affected9,531 at risk
|
| Diabetic vascular disorder | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Embolism arterial | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Embolism venous | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Extremity necrosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events5 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Hypertension | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG00040 events36 affected9,562 at risk
- EG00145 events45 affected9,531 at risk
|
| Hypertensive crisis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG00017 events15 affected9,562 at risk
- EG00125 events23 affected9,531 at risk
|
| Hypertensive emergency | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0004 events4 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Hypotension | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events9 affected9,562 at risk
- EG0017 events6 affected9,531 at risk
|
| Hypovolaemic shock | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Iliac artery disease | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Iliac artery embolism | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Intermittent claudication | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0009 events9 affected9,562 at risk
- EG0018 events7 affected9,531 at risk
|
| Labile blood pressure | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Lymphocele | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Lymphoedema | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Malignant hypertension | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Necrosis ischaemic | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Neurogenic shock | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0007 events7 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG00038 events31 affected9,562 at risk
- EG00160 events48 affected9,531 at risk
|
| Peripheral artery aneurysm | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Peripheral artery occlusion | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0013 events2 affected9,531 at risk
|
| Peripheral artery stenosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG00010 events10 affected9,562 at risk
- EG0014 events4 affected9,531 at risk
|
| Peripheral artery thrombosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0006 events5 affected9,562 at risk
- EG0016 events6 affected9,531 at risk
|
| Peripheral coldness | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Peripheral embolism | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Peripheral ischaemia | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG00017 events14 affected9,562 at risk
- EG00119 events18 affected9,531 at risk
|
| Peripheral vascular disorder | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0016 events5 affected9,531 at risk
|
| Peripheral venous disease | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0003 events3 affected9,562 at risk
- EG0013 events3 affected9,531 at risk
|
| Rheumatoid vasculitis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Shock | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Shock haemorrhagic | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0002 events2 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Subclavian artery stenosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Subgaleal haematoma | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Temporal arteritis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Thrombophlebitis superficial | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|
| Thrombosis | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Varicose vein | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vascular compression | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0011 events1 affected9,531 at risk
|
| Vascular occlusion | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0001 events1 affected9,562 at risk
- EG0010 events0 affected9,531 at risk
|
| Venous thrombosis limb | Vascular disorders | MedDRA 21.1 | Systematic Assessment | | - EG0000 events0 affected9,562 at risk
- EG0012 events2 affected9,531 at risk
|